CarGurus insider sale: 3,789 Class A shares proposed via Fidelity on NASDAQ
Rhea-AI Filing Summary
CarGurus insider Matthew Quinn reported a proposed sale of 3,789 Class A shares purchased via restricted stock vesting on 10/01/2025. The shares are to be sold through Fidelity Brokerage Services on NASDAQ around 10/02/2025 with an aggregate market value listed at $142,845.30 against 85,043,939 shares outstanding. The filing shows an earlier sale of 3,789 Class A shares on 07/02/2025 for $125,378.01. The securities were acquired as compensation and the filer attests to no undisclosed material adverse information.
Positive
- Clear disclosure of the sale transaction including broker, dates, and aggregate market value
- Transaction follows Rule 144 procedures with attestation about material nonpublic information
- Securities acquired as compensation via restricted stock vesting, with acquisition and payment dates documented
- Prior sale disclosed (3,789 shares on 07/02/2025), showing consistency in reporting
Negative
- None.
Insights
TL;DR: Routine insider sale of vested restricted stock; size is immaterial versus outstanding shares.
The filing documents a typical sale under Rule 144: 3,789 Class A shares from restricted stock vesting, executed via a broker on NASDAQ. The aggregate value ($142,845) represents roughly 0.0045% of the 85,043,939 shares outstanding, indicating minimal market impact. The prior sale of an equal number of shares on 07/02/2025 suggests periodic liquidity events rather than a concentrated divestiture. Disclosure and broker routing align with standard compliance practices.
TL;DR: Filing reflects compliant insider disposition with required attestations; no governance red flags evident.
The notice includes the required attestation regarding material nonpublic information and documents acquisition as restricted stock vesting with payment characterized as compensation. The use of a registered broker and explicit dates supports procedural adherence to Rule 144 and insider trading rules. No accelerated sales program or 10b5-1 plan date is indicated, and no material governance concerns are disclosed in the form itself.